“…A number of more novel diagnostic tests are currently undergoing research and development including the BT Test (Provista Life Sciences, Phoenix, Arizona, USA), a diagnostic blood test that measures a number of inflammatory and tumour related biomarkers, and a scan which interprets the structure of human hair (Fermiscan, Sydney, NSW, Australia). A recent study using the latter technology suggests that it may be possible to diagnose breast cancer in women of all ages using hair diffraction [12]. Preliminary results from both these approaches hold much promise (GCW-personal communication) and research trials are ongoing.…”